MAPT and Alzheimer disease: For example, various methods have been used to detect neurotoxic Aβ42 and Aβ40, phosphorylated tau, total tau, and neurofilament light chain in cerebrospinal fluid (CSF) and plasma; changes in the absolute quantities or ratios of these biomarkers are strongly associated with AD progression [4,5].